119 related articles for article (PubMed ID: 17876401)
1. Validation of the Brazilian version of Guy's neurological disability scale.
Araujo CR; Simão LM; Ybarra MI; Faria NV; Botelho CM; Moreira MA; Teixeira AL; Lana-Peixoto MA
Arq Neuropsiquiatr; 2007 Sep; 65(3A):615-8. PubMed ID: 17876401
[TBL] [Abstract][Full Text] [Related]
2. Psychometric properties of the Italian version of the Guy's Neurological Disability Scale.
Pappalardo A; Patti F
Funct Neurol; 2010; 25(4):223-33. PubMed ID: 21388584
[TBL] [Abstract][Full Text] [Related]
3. Validation of the Guy's Neurological Disability Scale as a screening tool for cognitive impairment in multiple sclerosis.
Akatani R; Chihara N; Tachibana H; Koto S; Kowa H; Kanda F; Matsumoto R; Toda T
Mult Scler Relat Disord; 2019 Oct; 35():272-275. PubMed ID: 31442905
[TBL] [Abstract][Full Text] [Related]
4. Psychometric testing of the Americanized version of the Guy's Neurological Disability Scale.
Fraser C; McGurl J
J Neurosci Nurs; 2007 Feb; 39(1):13-9. PubMed ID: 17396533
[TBL] [Abstract][Full Text] [Related]
5. Factor structure of Guy's Neurological Disability Scale in a sample of Dutch patients with multiple sclerosis.
Mokkink LB; Knol DL; Uitdehaag BM
Mult Scler; 2011 Dec; 17(12):1498-503. PubMed ID: 21828196
[TBL] [Abstract][Full Text] [Related]
6. One year changes in disability in multiple sclerosis: neurological examination compared with patient self report.
Hoogervorst EL; Eikelenboom MJ; Uitdehaag BM; Polman CH
J Neurol Neurosurg Psychiatry; 2003 Apr; 74(4):439-42. PubMed ID: 12640058
[TBL] [Abstract][Full Text] [Related]
7. The Guy's Neurological Disability Scale in patients with multiple sclerosis: a clinical evaluation of its reliability and validity.
Rossier P; Wade DT
Clin Rehabil; 2002 Feb; 16(1):75-95. PubMed ID: 11837529
[TBL] [Abstract][Full Text] [Related]
8. Validation of the Brazilian version of the patient-determined disease steps scale in persons with multiple sclerosis.
de David AC; Sasaki JE; Ramari C; Tauil CB; Moraes AG; Martins F; von Glehn F; Motl RW
Mult Scler Relat Disord; 2019 May; 30():208-214. PubMed ID: 30818129
[TBL] [Abstract][Full Text] [Related]
9. Comparisons of patient self-report, neurologic examination, and functional impairment in MS.
Hoogervorst EL; van Winsen LM; Eikelenboom MJ; Kalkers NF; Uitdehaag BM; Polman CH
Neurology; 2001 Apr; 56(7):934-7. PubMed ID: 11294932
[TBL] [Abstract][Full Text] [Related]
10. The INTERMED: a screening instrument to identify multiple sclerosis patients in need of multidisciplinary treatment.
Hoogervorst EL; de Jonge P; Jelles B; Huyse FJ; Heeres I; van der Ploeg HM; Uitdehaag BM; Polman CH
J Neurol Neurosurg Psychiatry; 2003 Jan; 74(1):20-4. PubMed ID: 12486260
[TBL] [Abstract][Full Text] [Related]
11. The Guy's Neurological Disability Scale (GNDS): a new disability measure for multiple sclerosis.
Sharrack B; Hughes RA
Mult Scler; 1999 Aug; 5(4):223-33. PubMed ID: 10467380
[TBL] [Abstract][Full Text] [Related]
12. Multiple Sclerosis Impact Scale (MSIS-29): relation to established measures of impairment and disability.
Hoogervorst EL; Zwemmer JN; Jelles B; Polman CH; Uitdehaag BM
Mult Scler; 2004 Oct; 10(5):569-74. PubMed ID: 15471375
[TBL] [Abstract][Full Text] [Related]
13. How similar are commonly combined criteria for EDSS progression in multiple sclerosis?
Kragt JJ; Nielsen IM; van der Linden FA; Uitdehaag BM; Polman CH
Mult Scler; 2006 Dec; 12(6):782-6. PubMed ID: 17263007
[TBL] [Abstract][Full Text] [Related]
14. The use of multi-domain patient reported outcome measures for detecting clinical disease progression in multiple sclerosis.
van 't Hullenaar CAA; Coerver E; Kalkers NF; van Kempen Z; Koch M; Uitdehaag BMJ; Killestein J; Strijbis EMM
Mult Scler Relat Disord; 2021 Oct; 55():103165. PubMed ID: 34404022
[TBL] [Abstract][Full Text] [Related]
15. A randomised placebo controlled exploratory study of vitamin B-12, lofepramine, and L-phenylalanine (the "Cari Loder regime") in the treatment of multiple sclerosis.
Wade DT; Young CA; Chaudhuri KR; Davidson DL
J Neurol Neurosurg Psychiatry; 2002 Sep; 73(3):246-9. PubMed ID: 12185153
[TBL] [Abstract][Full Text] [Related]
16. The patient's perception of a (reliable) change in the Multiple Sclerosis Functional Composite.
Hoogervorst EL; Kalkers NF; Cutter GR; Uitdehaag BM; Polman CH
Mult Scler; 2004 Feb; 10(1):55-60. PubMed ID: 14760953
[TBL] [Abstract][Full Text] [Related]
17. Validation of the Brazilian version of the neurological fatigue index for multiple sclerosis.
Lopes J; Lavado EL; Kaimen-Maciel DR
Arq Neuropsiquiatr; 2016 Apr; 74(4):320-8. PubMed ID: 27097006
[TBL] [Abstract][Full Text] [Related]
18. Yale-Brown Obsessive Compulsive Scale modified for Body Dysmorphic Disorder (BDD-YBOCS): Brazilian Portuguese translation, cultural adaptation and validation.
de Brito MJ; Sabino Neto M; de Oliveira MF; Cordás TA; Duarte LS; Rosella MF; Felix GA; Ferreira LM
Braz J Psychiatry; 2015; 37(4):310-6. PubMed ID: 26692429
[TBL] [Abstract][Full Text] [Related]
19. Cross-cultural adaptation and validation of the 12-item Multiple Sclerosis Walking Scale (MSWS-12) for the Brazilian population.
Marangoni BE; Pavan K; Tilbery CP
Arq Neuropsiquiatr; 2012 Dec; 70(12):922-8. PubMed ID: 23295419
[TBL] [Abstract][Full Text] [Related]
20. Enhancing the cross-cultural adaptation and validation process: linguistic and psychometric testing of the Brazilian-Portuguese version of a self-report measure for dry eye.
Santo RM; Ribeiro-Ferreira F; Alves MR; Epstein J; Novaes P
J Clin Epidemiol; 2015 Apr; 68(4):370-8. PubMed ID: 25619561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
